Patents by Inventor Runar Marteinsson

Runar Marteinsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220370680
    Abstract: Provided herein are chitosan-containing formulations, methods of making such formulations, and methods of using such formulations. Chitosan contemplated for use herein is preferably of high quality and its source is preferably of crustacean origin. The formulations contemplated herein are aqueous, either liquid- or viscous-like, varying in concentration and type of chitosan and acid used, and may include other components. Their uses are diverse, for oral/dental administration or topical/surface application to subjects (e.g. humans or animals) in need thereof or even food commodities, aiming to maintain a good condition where it is applied or contributing to health enhancement, healing, disease prevention or treatment. The present invention also relates to concentrated solutions that may be used for the formulation of other products.
    Type: Application
    Filed: August 3, 2022
    Publication date: November 24, 2022
    Applicant: Primex EHF.
    Inventors: Rúnar Marteinsson, Hélène L. Lauzon, Sigrídur Vigdís Vigfúsdóttir
  • Patent number: 11426486
    Abstract: Provided herein are chitosan-containing formulations, methods of making such formulations, and methods of using such formulations. Chitosan contemplated for use herein is preferably of high quality and its source is preferably of crustacean origin. The formulations contemplated herein are aqueous, either liquid- or viscous-like, varying in concentration and type of chitosan and acid used, and may include other components. Their uses are diverse, for oral/dental administration or topical/surface application to subjects (e.g. humans or animals) in need thereof or even food commodities, aiming to maintain a good condition where it is applied or contributing to health enhancement, healing, disease prevention or treatment. The present invention also relates to concentrated solutions that may be used for the formulation of other products.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: August 30, 2022
    Assignee: Primex EHF.
    Inventors: Rúnar Marteinsson, Hélène L. Lauzon, Sigrídur Vigdís Vigfúsdóttir
  • Patent number: 10988551
    Abstract: The present disclosure generally relates to improved processes for making chitosan salts and products formed by such processes. In certain embodiments, the processes disclosed herein provide the ability to make high-grade chitosan salts at lower cost and with improved environmental friendliness.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: April 27, 2021
    Assignee: PRIMEX EHF.
    Inventors: Runar Marteinsson, Hélène L. Lauzon
  • Publication number: 20200017608
    Abstract: The present disclosure generally relates to improved processes for making chitosan salts and products formed by such processes. In certain embodiments, the processes disclosed herein provide the ability to make high-grade chitosan salts at lower cost and with improved environmental friendliness.
    Type: Application
    Filed: July 9, 2019
    Publication date: January 16, 2020
    Applicant: Primex EHF.
    Inventors: Runar Marteinsson, Hélène L. Lauzon
  • Publication number: 20180296724
    Abstract: Provided herein are chitosan-containing formulations, methods of making such formulations, and methods of using such formulations. Chitosan contemplated for use herein is preferably of high quality and its source is preferably of crustacean origin. The formulations contemplated herein are aqueous, either liquid- or viscous-like, varying in concentration and type of chitosan and acid used, and may include other components. Their uses are diverse, for oral/dental administration or topical/surface application to subjects (e.g. humans or animals) in need thereof or even food commodities, aiming to maintain a good condition where it is applied or contributing to health enhancement, healing, disease prevention or treatment. The present invention also relates to concentrated solutions that may be used for the formulation of other products.
    Type: Application
    Filed: January 10, 2018
    Publication date: October 18, 2018
    Inventors: Rúnar Marteinsson, Hélène L. Lauzon, Sigrídur Vigdís Vigfúsdóttir